Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jessica Delorme

Biographic Data

ID7446808
NAMEJessica Delorme
GIVEN NAMESJessica
FAMILY NAMEDelorme
SIGNATUREDELORME J
AFFILIATIONSInserm
VERIFIEDNo
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use

    Open Access•Célian Bertin, Julien Bezin et al.•ARTICLE•Frontiers in Psychiatry•2022

    Patients that were prescribed oral morphine represented a small minority of the treated for OUD. The poorer health condition affected by numerous comorbidities and higher risk of opioid overdose in patients treated with oral morphine compared with OMT controls points toward the need to better supervise the practices of these patients, to strengthen multidisciplinary care and risk reduction measures

  • Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care

    Open Access•Catherine Laporte, Frédéric Fortin et al.•ARTICLE•International Journal of…•2022

    Analgesic opioid (AO) misuse by patients ranges from 0% to 50%. General practitioners are the first prescribers of AO. Our objective was to validate the Prescription Opioid Misuse Index (POMI) in primary care. We conducted a psychometric study in patients with chronic pain who had been taking AOs for at least 3 months and were followed in general practice. Patients responded to the POMI at inclusion and after 2 weeks. The reference used was the D…

  • Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients

    Open Access•Jessica Delorme, Lucie Pennel et al.•ARTICLE•Frontiers in Psychiatry•2021

    Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23-68% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to provide European estimates of the prevalence of chronic pain in patients receiving OAT using French data, since France is the first European country in …

  • Opioid Analgesic Prescription in French Children

    Open Access•Samira Choufi, Simon Mounier et al.•ARTICLE•International Journal of…•2021

    Codeine use was restricted in 2013 and is currently contraindicated for children below the age of 12 years. We examined how the prescription of opioid analgesics in children in France evolved between 2012 and 2018. Our population-based study from the SNIIRAM database (National System of Health Insurance Inter-Regime Information) was designed to determine trends in opioid prescription from 2012 to 2018 in all French children. The number of childre…

  • Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era

    Open Access•Teresa Rojas Rojas, Vincent Di Beo et al.•ARTICLE•International Journal of Drug…•2019

  • Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions

    Open Access•Jessica Delorme, Chouki Chenaf et al.•ARTICLE•Frontiers in Psychiatry•2018

    Treating pain and opioid use disorder represents a clinical challenge. While most studies that have assessed opioid analgesic use in opioid substitution treatment (OST) patients primarily address opioid analgesic misuse (Brands et al., 2004; Rosenblum et al., 2007), only few studies focused on OST patients assessed the prescription of analgesic opioids for chronic pain. We sought to compare the prevalence of analgesic opioid prescription (AOP) in…

No prominent works on this page.

  • Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions

    Open Access•Jessica Delorme, Chouki Chenaf et al.•ARTICLE•Frontiers in Psychiatry•2018

    Treating pain and opioid use disorder represents a clinical challenge. While most studies that have assessed opioid analgesic use in opioid substitution treatment (OST) patients primarily address opioid analgesic misuse (Brands et al., 2004; Rosenblum et al., 2007), only few studies focused on OST patients assessed the prescription of analgesic opioids for chronic pain. We sought to compare the prevalence of analgesic opioid prescription (AOP) in…

  • Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era

    Open Access•Teresa Rojas Rojas, Vincent Di Beo et al.•ARTICLE•International Journal of Drug…•2019

  • Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients

    Open Access•Jessica Delorme, Lucie Pennel et al.•ARTICLE•Frontiers in Psychiatry•2021

    Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23-68% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to provide European estimates of the prevalence of chronic pain in patients receiving OAT using French data, since France is the first European country in …

  • Opioid Analgesic Prescription in French Children

    Open Access•Samira Choufi, Simon Mounier et al.•ARTICLE•International Journal of…•2021

    Codeine use was restricted in 2013 and is currently contraindicated for children below the age of 12 years. We examined how the prescription of opioid analgesics in children in France evolved between 2012 and 2018. Our population-based study from the SNIIRAM database (National System of Health Insurance Inter-Regime Information) was designed to determine trends in opioid prescription from 2012 to 2018 in all French children. The number of childre…

  • Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use

    Open Access•Célian Bertin, Julien Bezin et al.•ARTICLE•Frontiers in Psychiatry•2022

    Patients that were prescribed oral morphine represented a small minority of the treated for OUD. The poorer health condition affected by numerous comorbidities and higher risk of opioid overdose in patients treated with oral morphine compared with OMT controls points toward the need to better supervise the practices of these patients, to strengthen multidisciplinary care and risk reduction measures

  • Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care

    Open Access•Catherine Laporte, Frédéric Fortin et al.•ARTICLE•International Journal of…•2022

    Analgesic opioid (AO) misuse by patients ranges from 0% to 50%. General practitioners are the first prescribers of AO. Our objective was to validate the Prescription Opioid Misuse Index (POMI) in primary care. We conducted a psychometric study in patients with chronic pain who had been taking AOs for at least 3 months and were followed in general practice. Patients responded to the POMI at inclusion and after 2 weeks. The reference used was the D…

Internal Medicine (6 works) · Medicine (6 works) · Opioid (6 works) · Opioid Use Disorder Treatment (5 works) · Pain Management and Opioid Use (5 works) · Anesthesia (4 works) · Analgesic (3 works) · Buprenorphine (3 works) · Medical prescription (3 works) · Methadone (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae